Sign in
Not yet taking people in United StatesNo phase

Validate the Temporal Stability and Responsiveness of AI-COA® for Depression and Anxiety

Key facts

Who runs it
Deliberate Solutions Inc.
Where
Houston, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
150 people, planned
Started
1 Mar 2026
Expected to end
28 Feb 2027
Type of study
Observational
Record updated
12 December 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • English fluency
  • 18 to 65 years of age
  • HAM-D 17 > 10
  • Starting, or has started, a new treatment for depression or anxiety within 2-3 weeks of enrollment
  • Access to a laptop or other computer with a well functioning microphone and webcam, and a stable Internet connection
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Resides in the United States at the time of consent and during completion of study

Who cannot take part

  • Concurrent medication/treatment:; Receiving any fast-acting treatment for depression or anxiety (e.g. ketamine, psychedelics, deep brain stimulation, etc.) in between initial baseline assessment (A1) and Restest (A2) , or in between Follow up assessment (B1) and Retest (B2); Anxiolytics: Use of benzodiazepines or other anxiety-reducing medications that could affect speech or motor activity, within the past 4 weeks; Antipsychotics and Mood Stabilizers: Medications that can alter cognitive and motor functions, within the past 6 weeks; Stimulants: Use of medications like methylphenidate or amphetamines that affect energy levels and behavior, within the past 2 weeks; Epilepsy medication: seizure activity or medication side effects that may alter behavior, within the past 4 weeks
  • Participants who have previously participated in another research project by Deliberate
  • Any cognitive impairment that limits ability to provide informed consent or authorization
  • Impairment that would prevent participants from completing an online survey and/or engaging in clinician assessment interviews (e.g., visual impairment, motor impairment, hearing impairment)
  • Any history or evidence of any of the following conditions:; Neurodevelopmental, Neurocognitive, Neurodegenerative or movement disorders including, but not limited to:; Tourette's syndrome; Multiple Sclerosis; Amyotrophic Lateral Sclerosis; Parkinson's Disease; Stroke; Traumatic Brain Injury; Facial paralysis
  • Conditions with vocal cord impact:; Vocal cord injury or cerebrovascular accident or head trauma with residual dysarthria in the past year; Disorders that may impact vocal cords such as acute or chronic laryngitis, vocal cord paresis or paralysis, or spasmodic dysphonia; Past or active heavy smokers (an average of >20 cigarettes per day)
  • Schizophrenia Spectrum and Other Psychotic Disorders:; Individuals with a current or past diagnosis of Schizophrenia, Schizoaffective Disorder, or other psychotic disorders, including Delusional Disorder and Brief Psychotic Disorder; Current hypomanic episode as defined by DSM-5 criteria. This includes those with Bipolar I Disorder, Bipolar II Disorder, or Cyclothymic Disorder who are not in a stable mood state at the time of assessment; Chronic Pain Conditions: Such as fibromyalgia, which may affect facial expressions and vocal tone; Prosthetic Facial Devices: Could affect facial recognition algorithms. Cosmetic Procedures: Such as Botox injections or facelifts that can impact facial expressions; Dental Work: Major procedures that might affect speech
  • Vulnerable or protected populations (e.g. prisoners)
  • Acute intoxication at the time of the assessments

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • Baylor College of MedicineHouston, United StatesContact: Eric Storch, PhDNot yet recruiting

About the trial

What the trial wants to find out

This study evaluates the reliability and responsiveness of the AI-COA®, a digital tool designed to assess the severity of depression and anxiety. The study compares the tool's performance against standard clinician ratings over 12 weeks to determine its consistency and sensitivity to symptom changes.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Symptom Evaluation and Quantification for Unified Outcomes and Individualized Assessment
Fit questions
Built from NCT07279025, who can take part
Record updated
12 December 2025